Status:
COMPLETED
Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia
Lead Sponsor:
Egymedicalpedia
Collaborating Sponsors:
Al-Azhar University
Conditions:
Iron Deficiency Anemia
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world. ID and IDA, particularly caused by increased iron requirements during pregnancy; represe...
Detailed Description
The World Health Organization (WHO) defines anemia in pregnancy as a hemoglobin (Hb) concentration of \< 11 g/dl. Centers for disease control \&prevention determine a cut of -off point 10.5 g/dl durin...
Eligibility Criteria
Inclusion
- Pregnant women with single fetus
- All pregnant women in 3rd trimester (28w\_36w) complaining of mild IDA
- Iron Deficiency Anemia mild anemia (hemoglobin level \< 11 mg/dl , and serum ferritin level \< 12 mg/dl).
Exclusion
- Patients with a history of anemia due to any other causes such as chronic blood loss, hemolytic anemia, and thalassemia.
- Clinical and/or laboratory evidence of hepatic, renal, cardiovascular abnormalities.
- History of peptic disorders.
- Esophagitis
- Hiatal hernia
- Malabsorption syndrome
Key Trial Info
Start Date :
June 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2024
Estimated Enrollment :
399 Patients enrolled
Trial Details
Trial ID
NCT06590831
Start Date
June 10 2023
End Date
June 10 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University hospitals
Asyut, Egypt